Moderna, Inc. company logo
Moderna, Inc. logo

Moderna, Inc. (MRNA) Selling, General & Administrative Expenses

Annual SG&A

$1.17B$375.00M-24.21%

Summary

Current Value
As of today, MRNA annual SG&A is $1.17B, down -24.21% on
Historical Performance
MRNA annual SG&A is up +107.05% over the past 3 years, and up +967.27% over the past 5 years
All-Time High Comparison
MRNA annual SG&A is currently -24.21% below its historical high of $1.55B set on
3-Year Low Comparison
MRNA annual SG&A is +3.71% above its 3-year low of $1.13B reached on an earlier date
Sector Comparison
MRNA annual SG&A is higher than 97.04% of companies in Healthcare sector

SG&A Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MRNA Performance
MetricDateValue1Y3Y5Y15Y
Annual SG&A$1.17B-24.2%+107.0%+967.3%+10000.0%
Quarterly SG&A$268.00M-4.6%-3.6%+452.1%+6674.5%
TTM SG&A$35.42B+2639.1%+3597.0%+10000.0%+10000.0%
Price$33.84-3.7%-82.4%-72.7%
Annual Operating Expenses$5.72B-9.3%+213.6%+862.5%+10000.0%
Annual Operating Profit-$3.95B+6.9%-129.7%-622.5%-10000.0%
Annual D&A$189.00M-69.6%-18.5%+509.3%+7878.1%
Annual Revenue$3.24B-52.7%-82.4%+5274.6%+10000.0%

SG&A Highs

MRNA Annual SG&A Highs Comparison
PeriodHighDateCurrent
3Y$1.55B-24.2%
5Y$1.55B-24.2%
All$1.55B-24.2%

SG&A Lows

MRNA Annual SG&A Lows Comparison
PeriodLowDateCurrent
3Y$1.13BN/A+3.7%
5Y$188.00MN/A+524.5%
All$400.00K>+9999.0%

SG&A History

YearValueChange
$1.17B-24.2%
$1.55B+36.8%
$1.13B+99.6%
$567.00M+201.6%
$188.00M+70.9%
$110.00M+16.7%
$94.25M+45.6%
$64.72M+12.7%
$57.45M+1,385.3%
$3.87M+16.0%
$3.33M+88.9%
$1.77M-66.4%
$5.25M-37.3%
$8.37M-19.2%
$10.36M+2.7%
$10.09M-25.9%
YearValueChange
$13.62M-33.0%
$20.31M+43.0%
$14.21M+30.4%
$10.90M+21.1%
$9.00M+11.7%
$8.06M-21.0%
$10.20M+136.0%
$4.32M-36.3%
$6.79M+65.6%
$4.10M+5.1%
$3.90M-22.0%
$5.00M+257.1%
$1.40M-46.2%
$2.60M+23.8%
$2.10M+425.0%
$400.00K-

FAQ

  • What is the current annual SG&A of MRNA?

    As of today, MRNA annual SG&A is $1.17B

  • What is 1-year change in MRNA annual SG&A?

    MRNA annual SG&A is down -24.21% year-over-year

  • What is 3-year change in MRNA annual SG&A?

    MRNA annual SG&A is up +107.05% over the past 3 years

  • How far is MRNA annual SG&A from its all-time high?

    MRNA annual SG&A is currently -24.21% below its historical high of $1.55B set on December 31, 2023

  • How does MRNA annual SG&A rank versus sector peers?

    MRNA annual SG&A is higher than 97.04% of companies in Healthcare sector

  • When is MRNA next annual earnings release?

    The next annual earnings release for MRNA is on

Selling, General & Administrative Expenses Formula

SG&A = − R&D

Data Sources & References

  1. MRNA Official Website www.modernatx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
  4. MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
  5. MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna